The effect of interleukin-1α and the glucocorticoid receptor blocker RU 38486 on total and myofibrillar protein breakdown in skeletal muscle

This publication has 14 references indexed in Scilit:

• Regulation of total and myofibrillar protein breakdown in rat extensor digitorum longus and soleus muscle incubated flaccid or at resting length
  Biochemical Journal, 1990
• Is There a Circulating Proteolysis-Inducing Factor During Sepsis?
  Archives of Surgery, 1990
• Corticosterone alone does not explain increased muscle proteolysis in septic rats
  Journal of Surgical Research, 1990
• Total and myofibrillar protein breakdown in different types of rat skeletal muscle: Effects of sepsis and regulation by insulin
  Metabolism, 1989
• Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents.
  Journal of Clinical Investigation, 1987
• Interleukin 1 and tumor necrosis factor do not regulate protein balance in skeletal muscle
  American Journal of Physiology-Cell Physiology, 1987
• Blockade of Glucocorticoid Receptor Binding and Inhibition of Dexamethasone-Induced Muscle Atrophy in the Rat by RU38486, a Potent Glucocorticoid Antagonist*
  Endocrinology, 1986
• RU 38486: A potent antiglucocorticoid in vitro and in vivo
  The Journal of Steroid Biochemistry and Molecular Biology, 1985
• Stimulation of Muscle Protein Degradation and Prostaglandin E₂Release by Leukocytic Pyrogen (Interleukin-1)
  New England Journal of Medicine, 1983
• Muscle Proteolysis Induced by a Circulating Peptide in Patients with Sepsis or Trauma
  New England Journal of Medicine, 1983